Приклади вживання The dose may be increased Англійська мовою та їх переклад на Українською
{-}
-
Colloquial
-
Ecclesiastic
-
Computer
The dose may be increased by one tablet.
Following an additional week the dose may be increased to 450 mg(22.5 ml) per day.
The dose may be increased to two inhalations if required.
If necessary(starting biliary colic), the dose may be increased to 20 drops per reception.
The dose may be increased depending on the clinical effect.
Depending on individual efficacy and tolerability, the dose may be increased to a maximum of 200 mg or reduced to 50 mg.
But the dose may be increased if the target is not achieved.
The dose may be increased to 8 mg once daily after one month of treatment.
If this dose is well tolerated after a minimum of two weeks of treatment, the dose may be increased to 3 mg twice a day.
In some cases the dose may be increased to 1.5-2 g/ day in 2 admissions.
For patients requiring further reduction inblood pressure after 2 weeks of therapy, the dose may be increased to 40 mg once daily.
The dose may be increased depending on the clinical response of the patient.
Depending on the adequacy of the response or side effects, the dose may be increased to 20 mg or decreased to 5 mg a day.
The dose may be increased depending on the clinical response of the patient.
Depending on the adequacy of the response or side effects, the dose may be increased to 200 mg or decreased to 50 mg a day.
In such cases, the dose may be increased at the end of the second week of treatment.
Depending on the individual activity of the disease and tolerability by the patient, the dose may be increased gradually by 2.5 mg(1.25 ml) per week.
The dose may be increased by 10 mg until a therapeutic response is obtained.
In the absence of excessive hypotension orsignificant deterioration of renalfunction, the dose may be increased at weekly intervals based on clinical and hemodynamicresponse.
The dose may be increased by 10 mg each week until the required response is obtained.
In the absence of excessive hypotension orsignificant deterioration of renal function, the dose may be increased at weekly intervals based on clinical and hemodynamic response.
The dose may be increased to 4 mg(and then, if necessary, to 6 mg) after adequate time has been allowed for the full pharmacological effect to occur.
For the treatment of adult patients with severe airway obstruction, the dose may be increased to 40 mg/ day, but such treatment should be performed under in-patient conditions under close medical supervision.
The dose may be increased by the physician to up to 30 units if required by the individual needs of the patients, with at least‘3-months' interval between treatments.
At repeat treatment sessions, the dose may be increased up to two-fold if the response to the initial treatment is considered insufficient.
For patients requiring additional symptomatic relief, the dose may be increased every 4-7 days to a maximum of 0.54 mg of base(0.75 mg of salt) per day(as shown in the table below).
If clinically indicated, the dose may be increased by a maximum of 600 mg/day at approximately weekly intervals from the starting dose to achieve the desired clinical response.